During the past decade, Grupo Medico Camino S.C. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grupo Medico Camino S.C." #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Grupo Medico Camino S.C." are "Atopic Dermatitis" (3 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Grupo Medico Camino S.C." in a lesser frequency.

Most popular intervention types in "Grupo Medico Camino S.C." are "Drug" (20 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ocrelizumab" (5 trials), "Abemaciclib" (2 trials), "Baricitinib" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grupo Medico Camino S.C." are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Grupo Medico Camino S.C.". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Grupo Medico Camino S.C., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Grupo Medico Camino S.C., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".